Profound Medical Corp. (TSX:PRN)
9.51
-0.04 (-0.42%)
May 22, 2026, 4:00 PM EST
Profound Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 50.3 | 59.72 | 54.91 | 26.21 | 46.52 | 67.15 |
Cash & Short-Term Investments | 50.3 | 59.72 | 54.91 | 26.21 | 46.52 | 67.15 |
Cash Growth | 8.32% | 8.76% | 109.48% | -43.65% | -30.73% | -19.97% |
Accounts Receivable | 9.42 | 7.2 | 6.43 | 6.75 | 5.84 | 1.41 |
Other Receivables | - | - | 0.62 | 0.53 | 0.51 | - |
Receivables | 9.42 | 7.2 | 7.05 | 7.29 | 6.34 | 1.41 |
Inventory | 9 | 8.24 | 5.8 | 6.99 | 7.94 | 7.41 |
Prepaid Expenses | 0.81 | 0.93 | 1.31 | 1.41 | 1.22 | 1.15 |
Total Current Assets | 69.53 | 76.09 | 69.07 | 41.9 | 62.02 | 77.13 |
Property, Plant & Equipment | 3.58 | 0.88 | 0.82 | 1.57 | 1.72 | 1.9 |
Goodwill | - | - | - | - | - | 2.69 |
Other Intangible Assets | 0.13 | 0.14 | 0.26 | 0.49 | 0.68 | 1.44 |
Long-Term Accounts Receivable | 0.15 | 0.3 | - | - | - | 3.62 |
Long-Term Deferred Tax Assets | 0.07 | 0.07 | 0.09 | - | - | - |
Total Assets | 73.46 | 77.48 | 70.23 | 43.96 | 64.42 | 86.78 |
Accounts Payable | 2.14 | 1.56 | 1.32 | 0.87 | 2.03 | 3.18 |
Accrued Expenses | 3.39 | 3.82 | 2.84 | 2.42 | - | - |
Current Portion of Long-Term Debt | 4.5 | - | 1.74 | 2.1 | 0.52 | - |
Current Portion of Leases | 0.07 | 0.21 | 0.26 | 0.26 | 0.24 | 0.25 |
Current Income Taxes Payable | 0.04 | 0.04 | - | - | 0.3 | - |
Current Unearned Revenue | 0.46 | 0.45 | 0.42 | 0.72 | 0.47 | 0.48 |
Other Current Liabilities | - | - | - | - | 0.62 | 0.25 |
Total Current Liabilities | 10.61 | 6.08 | 6.57 | 6.37 | 4.18 | 4.16 |
Long-Term Debt | - | 4.5 | 2.92 | 5 | 6.65 | - |
Long-Term Leases | 2.89 | - | 0.2 | 0.5 | 0.82 | 1.13 |
Long-Term Unearned Revenue | 0.44 | 0.39 | 0.05 | 0.73 | 0.76 | 0.88 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.06 | - | - |
Other Long-Term Liabilities | 0.09 | 0.08 | 0.07 | 0.07 | - | - |
Total Liabilities | 14.03 | 11.04 | 9.81 | 12.73 | 12.42 | 6.16 |
Common Stock | 324.16 | 323.84 | 281.55 | 222.21 | 205.83 | 219.58 |
Additional Paid-In Capital | 26.03 | 25.31 | 21.3 | 20.81 | 18.7 | 16.99 |
Retained Earnings | -294.79 | -287.74 | -245.17 | -217.35 | -189.36 | -160.69 |
Comprehensive Income & Other | 4.02 | 5.03 | 2.74 | 5.57 | 16.84 | 4.75 |
Shareholders' Equity | 59.42 | 66.43 | 60.42 | 31.22 | 52 | 80.62 |
Total Liabilities & Equity | 73.46 | 77.48 | 70.23 | 43.96 | 64.42 | 86.78 |
Total Debt | 7.46 | 4.71 | 5.12 | 7.87 | 8.23 | 1.38 |
Net Cash (Debt) | 42.83 | 55.01 | 49.79 | 18.35 | 38.29 | 65.78 |
Net Cash Growth | 3.08% | 10.48% | 171.40% | -52.08% | -41.79% | -20.02% |
Net Cash Per Share | 1.35 | 1.82 | 2.01 | 0.87 | 1.84 | 3.21 |
Filing Date Shares Outstanding | 36.34 | 36.29 | 30.04 | 24.43 | 20.91 | 20.78 |
Total Common Shares Outstanding | 36.34 | 36.29 | 30.04 | 21.37 | 20.88 | 20.78 |
Working Capital | 58.92 | 70.01 | 62.5 | 35.53 | 57.84 | 72.97 |
Book Value Per Share | 1.64 | 1.83 | 2.01 | 1.46 | 2.49 | 3.88 |
Tangible Book Value | 59.3 | 66.3 | 60.16 | 30.73 | 51.32 | 76.49 |
Tangible Book Value Per Share | 1.63 | 1.83 | 2.00 | 1.44 | 2.46 | 3.68 |
Machinery | - | 1.75 | 2.27 | 2.58 | 0.54 | 1.2 |
Leasehold Improvements | - | 0.54 | 0.54 | 0.54 | 1.84 | 0.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.